Compare HRMY & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | LWLG |
|---|---|---|
| Founded | 2017 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2020 | 2011 |
| Metric | HRMY | LWLG |
|---|---|---|
| Price | $33.41 | $9.58 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $44.11 | N/A |
| AVG Volume (30 Days) | 718.4K | ★ 5.0M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.97 | ★ 15.79 |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $868,453,000.00 | $236,855.00 |
| Revenue This Year | $19.75 | N/A |
| Revenue Next Year | $12.88 | N/A |
| P/E Ratio | $60.29 | ★ N/A |
| Revenue Growth | 21.51 | ★ 147.74 |
| 52 Week Low | $25.52 | $1.19 |
| 52 Week High | $40.87 | $18.71 |
| Indicator | HRMY | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 54.50 | 42.85 |
| Support Level | $31.61 | $3.46 |
| Resistance Level | $35.47 | $13.65 |
| Average True Range (ATR) | 1.14 | 1.10 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 49.14 | 19.71 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.